All In Biotech

Drug Trial Radar · NCT02405104

Chlorzoxazone in Hip and Knee Arthroplasty

Analgetic Effects of Chlorzoxazone in Total Hip and Knee Arthroplasty

Last checked: Nov 20, 2026Latest source record: Sep 9, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 400 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

400

Actual

Start

Sep 1, 2015

Primary completion

Dec 31, 2017

Study completion Jul 31, 2019

Sponsor

Lead sponsor
Northern Orthopaedic Division, DenmarkAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Apr 1, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to elucidate whether patients operated with THA and TKA can benefit from treatment with chlorzoxazone.

Conditions

  • Osteoarthritis of Hip
  • Osteoarthritis, Knee

Interventions

  • chlorzoxazoneDrug

    ATC-code: M03BB03

  • PlaceboDrug

    Placebo

  • THAProcedure

    Surgical treatment of osteoarthrosis in the hip, by replacement.

  • TKAProcedure

    Surgical treatment of osteoarthrosis in the knee, by replacement.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Pain after 5 meter walkTime frame: 24 hours post OP

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Northern Orthopaedic Division, Clinic Farsø, Aalborg University Hospital

    Farsø, Northern Jutland, Denmark

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.